Keyphrases
Hemophilia
100%
Indonesia
77%
Severe Haemophilia A
60%
Dose Factor
44%
On Demand
44%
Single-center Experience
44%
Indonesian
44%
Joint Bleeding
38%
Jakarta
30%
Low-dose Prophylaxis
27%
Population Pharmacokinetics
27%
Factor VIII Inhibitor
27%
Pharmacokinetic Profile
26%
Transfusion
25%
Factor VIII Prophylaxis
22%
Hemosiderin Deposition
22%
Imaging Sequences
22%
Plasma-derived
22%
Joint Association
22%
Gradient Echo
22%
Nucleic Acid Testing
22%
Blood Donor Screening
22%
Bleeding Disorders
22%
Joint Outcome
22%
Haemophilia Treatment Centre
22%
Episodic Treatment
22%
Tertiary Prophylaxis
22%
On-demand Treatment
22%
Arthropathy
22%
D-dimer
22%
β-Thalassemia (β-thal)
22%
Pharmacokinetic Model
22%
Screening Method
22%
Haemophilia Care
22%
Acute Leukemia
22%
Hemostatic Abnormalities
22%
Pada
22%
Urinary Tract Infection
22%
Children with Thalassemia
22%
Late-onset
22%
Non-Hodgkin Lymphoma
22%
Treatment Outcome
22%
Coagulation System
22%
Ultrasound
22%
Magnetic Resonance Imaging
22%
Von Willebrand Factor
22%
Haemo-QoL
22%
Liver Iron Overload
22%
Hepatitis C
22%
Neonatal Sepsis
22%
Medicine and Dentistry
Haemophilia
93%
Haemophilia A
67%
Blood Clotting Factor 8 Inhibitor
32%
Oncology
29%
Echography
25%
Hemosiderin
22%
Posttransfusion Hepatitis
22%
Nucleic Acid
22%
Bleeding Disorder
22%
Ankle Joint
22%
Magnetic Resonance Imaging
22%
Hemostat
22%
Iron Overload
22%
Thalassemia Major
22%
Low Drug Dose
22%
Blood Clotting Factor 8
22%
Non-Hodgkin Lymphoma
22%
Hepatitis C
22%
Screening
22%
Blood Donor
22%
Pediatric Hematology
22%
Hemarthrosis
19%
Prevalence
14%
Cross Sectional Study
13%
Partial Thromboplastin Time
13%
Arthropathy
13%
Blood Transfusion
13%
Ciclonicate
12%
Haemophilia B
11%
Thrombocytopenia
11%
Hepatitis C Virus
11%
Bleeding
9%
Pediatrics
8%
Prothrombin Time
8%
Infusion
7%
Juvenile Idiopathic Arthritis
7%
Thalassemia
5%
Quality of Life
5%
Physical Activity
5%
Test Retest Reliability
5%
Joint Destruction
5%
Medical Record
5%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 8
66%
Haemophilia A
66%
Pharmacokinetics
44%
Haemophilia
32%
Blood Clotting Factor 8 Inhibitor
25%
Acute Leukemia
22%
Thalassemia Major
22%
Blood Clotting Factor 8 Concentrate
22%
D Dimer
22%
Dimer
22%
Iron Poisoning
22%
Newborn Sepsis
22%
Nonhodgkin Lymphoma
22%
Urinary Tract Infection
22%
Hemostatic Agent
22%
Von Willebrand Factor
22%
Sepsis
19%
Thromboplastin
18%
Prevalence
13%
Hemarthrosis
13%
Cross-Sectional Study
12%
Prothrombin
12%
Thrombocytopenia
11%
Blood Clotting Factor 8 Plus Von Willebrand Factor
9%
Acute Lymphoblastic Leukemia
8%
Acute Myeloid Leukemia
8%
Bleeding
8%
Arthropathy
7%
Prematurity
6%
Thalassemia
5%